Baxter Recalls CARDENE IV Nicardipine Injection Due to Manufacturing Deviations
Baxter Healthcare is voluntarily recalling specific lots of CARDENE IV (Nicardipine Hydrochloride) injection due to CGMP deviations. The recall covers products distributed in the US, Puerto Rico, and Chile.
- Product
- CARDENE IV — CARDENE IV (NICARDIPINE HYDROCHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide